As I can tell from his post, Doc328 was not advertising the wonderful working of Belsomra.
He/she was merely pointing out what incredible hurdles a big pharma must take to submit a successful submission with the FDA for a drug approval for Alzheimer related sleep disturbances(64 patient study measured sleep with polysomnogram and also measured CGI-S and a caregiver-reported participant subjective Sleep Quality Rating), let alone a small biotech....
Market Data 
Markets 
AI
